pennslammeriii3500| The concept of non-alcoholic steatohepatitis (NASH) rises in intraday trading, Kanghong Pharmaceutical's daily limit

editor|
15

April 25pennslammeriii3500, the concept of non-alcoholic steatohepatitis (NASH) rose intraday. As of 11:04, the overall index of the concept of non-alcoholic steatohepatitis (NASH) rose by 3pennslammeriii3500.00%, reporting 1,054.820 points.

From the perspective of individual stocks, among the components of this concept, Kanghong Pharmaceutical has a daily limit, and Microchip Biotech has increased by more than 5%.

From a financial point of view, as of press time, the main net inflow of the non-alcoholic steatohepatitis (NASH) concept was 71.727 million yuan, of which Kanghong Pharmaceutical was popular with funds, with a main net inflow of 35.6965 million yuan; Looking at the extended timeline, the net inflow of the main capital of the sector in the past 20 days was-469 million yuan.

pennslammeriii3500| The concept of non-alcoholic steatohepatitis (NASH) rises in intraday trading, Kanghong Pharmaceutical's daily limit

(The above content is Tencent's self-selected shares based on public information and intelligently generated by programs or algorithms. It is only used as a reference for users to watch the market, and is not used as investment advice or trading basis. The stock market is risky, please make decisions carefully.)